BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31713888)

  • 1. Novel genetic variants in HDAC2 and PPARGC1A of the CREB-binding protein pathway predict survival of non-small-cell lung cancer.
    Tang D; Zhao YC; Qian D; Liu H; Luo S; Patz EF; Moorman PG; Su L; Shen S; Christiani DC; Glass C; Gao W; Wei Q
    Mol Carcinog; 2020 Jan; 59(1):104-115. PubMed ID: 31713888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentially functional genetic variants in PLIN2, SULT2A1 and UGT1A9 genes of the ketone pathway and survival of nonsmall cell lung cancer.
    Tang D; Zhao YC; Liu H; Luo S; Clarke JM; Glass C; Su L; Shen S; Christiani DC; Gao W; Wei Q
    Int J Cancer; 2020 Sep; 147(6):1559-1570. PubMed ID: 32072637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentially functional genetic variants in the TNF/TNFR signaling pathway genes predict survival of patients with non-small cell lung cancer in the PLCO cancer screening trial.
    Guo Y; Feng Y; Liu H; Luo S; Clarke JW; Moorman PG; Su L; Shen S; Christiani DC; Wei Q
    Mol Carcinog; 2019 Jul; 58(7):1094-1104. PubMed ID: 30989732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentially functional genetic variants in the complement-related immunity gene-set are associated with non-small cell lung cancer survival.
    Qian D; Liu H; Wang X; Ge J; Luo S; Patz EF; Moorman PG; Su L; Shen S; Christiani DC; Wei Q
    Int J Cancer; 2019 Apr; 144(8):1867-1876. PubMed ID: 30259978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentially functional variants of HBEGF and ITPR3 in GnRH signaling pathway genes predict survival of non-small cell lung cancer patients.
    Wu Y; Liu Z; Tang D; Liu H; Luo S; Stinchcombe TE; Glass C; Su L; Lin L; Christiani DC; Wang Q; Wei Q
    Transl Res; 2021 Jul; 233():92-103. PubMed ID: 33400994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel genetic variants in KIF16B and NEDD4L in the endosome-related genes are associated with nonsmall cell lung cancer survival.
    Yang S; Tang D; Zhao YC; Liu H; Luo S; Stinchcombe TE; Glass C; Su L; Shen S; Christiani DC; Wang Q; Wei Q
    Int J Cancer; 2020 Jul; 147(2):392-403. PubMed ID: 31618441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variant of IRAK2 in the toll-like receptor signaling pathway and survival of non-small cell lung cancer.
    Xu Y; Liu H; Liu S; Wang Y; Xie J; Stinchcombe TE; Su L; Zhang R; Christiani DC; Li W; Wei Q
    Int J Cancer; 2018 Nov; 143(10):2400-2408. PubMed ID: 29978465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variants in RUNX3, AMD1 and MSRA in the methionine metabolic pathway and survival in nonsmall cell lung cancer patients.
    Chen K; Liu H; Liu Z; Luo S; Patz EF; Moorman PG; Su L; Shen S; Christiani DC; Wei Q
    Int J Cancer; 2019 Aug; 145(3):621-631. PubMed ID: 30650190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Variants of
    Zhao YC; Tang D; Yang S; Liu H; Luo S; Stinchcombe TE; Glass C; Su L; Shen S; Christiani DC; Wei Q
    Cancer Epidemiol Biomarkers Prev; 2020 Aug; 29(8):1679-1688. PubMed ID: 32493705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variants of CHEK1, PRIM2 and CDK6 in the mitotic phase-related pathway are associated with nonsmall cell lung cancer survival.
    Mu R; Liu H; Luo S; Patz EF; Glass C; Su L; Du M; Christiani DC; Jin L; Wei Q
    Int J Cancer; 2021 Sep; 149(6):1302-1312. PubMed ID: 34058013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variants in DDO and PEX5L in peroxisome-related pathways predict non-small cell lung cancer survival.
    Chen AS; Liu H; Wu Y; Luo S; Patz EF; Glass C; Su L; Du M; Christiani DC; Wei Q
    Mol Carcinog; 2022 Jul; 61(7):619-628. PubMed ID: 35502931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentially functional variants of ERAP1, PSMF1 and NCF2 in the MHC-I-related pathway predict non-small cell lung cancer survival.
    Yang S; Tang D; Zhao YC; Liu H; Luo S; Stinchcombe TE; Glass C; Su L; Shen S; Christiani DC; Wang Q; Wei Q
    Cancer Immunol Immunother; 2021 Oct; 70(10):2819-2833. PubMed ID: 33651148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variants of genes in the Notch signaling pathway predict overall survival of non-small cell lung cancer patients in the PLCO study.
    Xu Y; Wang Y; Liu H; Kang X; Li W; Wei Q
    Oncotarget; 2016 Sep; 7(38):61716-61727. PubMed ID: 27557513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel genetic variants in genes of the Fc gamma receptor-mediated phagocytosis pathway predict non-small cell lung cancer survival.
    Qian D; Liu H; Zhao L; Wang X; Luo S; Moorman PG; Patz EF; Su L; Shen S; Christiani DC; Wei Q
    Transl Lung Cancer Res; 2020 Jun; 9(3):575-586. PubMed ID: 32676321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variants in ABCG1 are associated with survival of nonsmall-cell lung cancer patients.
    Wang Y; Liu H; Ready NE; Su L; Wei Y; Christiani DC; Wei Q
    Int J Cancer; 2016 Jun; 138(11):2592-601. PubMed ID: 26757251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPARGC1A is upregulated and facilitates lung cancer metastasis.
    Li JD; Feng QC; Qi Y; Cui G; Zhao S
    Exp Cell Res; 2017 Oct; 359(2):356-360. PubMed ID: 28803067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel genetic variants of
    Liu L; Liu H; Luo S; Patz EF; Glass C; Su L; Lin L; Christiani DC; Wei Q
    Am J Cancer Res; 2020; 10(8):2603-2616. PubMed ID: 32905494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of polymorphisms at HORMAD2 and prognosis in advanced non-small-cell lung cancer patients.
    Zhang K; Tang S; Cao S; Hu L; Pan Y; Ma H; Guo X; Wu S; Shen H; Hu Z
    Cancer Epidemiol; 2014 Aug; 38(4):414-8. PubMed ID: 24797335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variants of
    Tang D; Liu H; Zhao Y; Qian D; Luo S; Patz EF; Su L; Shen S; ChristianI DC; Gao W; Wei Q
    Am J Cancer Res; 2020; 10(8):2582-2595. PubMed ID: 32905523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-radiation inhibits histone deacetylase 1 and 2, upregulates Axin expression and induces apoptosis in non-small cell lung cancer.
    Han Y; Zhang Y; Yang LH; Mi XY; Dai SD; Li QC; Xu HT; Yu JH; Li G; Zhao J; Han C; Yuan XM; Wang EH
    Radiat Oncol; 2012 Oct; 7():183. PubMed ID: 23110995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.